Rebuttal: Are drugs too expensive in Canada? - Yes

被引：0

作者：

Lexchin, Joel ^{[1
]}

机构：

[1] York Univ, Sch Hlth Policy & Management, Toronto, ON M3J 2R7, Canada

[2] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada

来源：

CANADIAN FAMILY PHYSICIAN | 2006年 / 52卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：841 / 842

页数：2

共 11 条

[1]

Canadian Institute for Health Information, 2005, DRUG EXP CAN 1985 20

[2] Pricing medicines: Theory and practice, challenges and opportunities [J].

Gregson, N ;

Sparrowhawk, K ;

Mauskopf, J ;

Paul, J .

NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (02) :121-130

[3]

Griffith JL, 2003, JAMA-J AM MED ASSOC, V289, P178

[4] Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies [J].

Lazarou, J ;

Pomeranz, BH ;

Corey, PN .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1200-1205

[5] Do manufacturers of brand-name drugs engage in price competition? An analysis of introductory prices [J].

Lexchin, J .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (08) :1120-1121

[6] The effect of generic competition on the price of brand-name drugs [J].

Lexchin, J .

HEALTH POLICY, 2004, 68 (01) :47-54

[7] Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study [J].

Mamdani, M ;

Juurlink, DN ;

Kopp, A ;

Naglie, G ;

Austin, PC ;

Laupacis, A .

BRITISH MEDICAL JOURNAL, 2004, 328 (7453) :1415-1416

[8]

Mintzes Barbara, 2005, Can J Clin Pharmacol, V12, pe22

[9] Cash interests taint drug advice [J].

Taylor, R ;

Giles, J .

NATURE, 2005, 437 (7062) :1070-1071

[10]

WENTE M, 2005, GLOBE MAIL 0726, P13

← 1 2 →